Atrial Fibrillation New Onset Clinical Trial
Official title:
The Effect of Silymarin on the Prevention of Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
The study is a prospective, randomized, controlled trial to assess the effects of silymarin on the occurrence of postoperative atrial fibrillation after coronary artery bypass graft surgery.
Postoperative atrial fibrillation (POAF) is a frequent complication after coronary artery bypass graft (CABG) surgery and is associated with increased mortality. So far, the effects of various drugs and supplements on the occurrence of postoperative atrial fibrillation (POAF) have been studied, but no one has looked into the effect of silymarin on the occurrence of POAF. The study is designed as a prospective, randomized, controlled trial to assess the effects of silymarin on the occurrence of postoperative atrial fibrillation after CABG surgery. A total of 160 patients of both sexes scheduled for elective CABG surgery using cardiopulmonary bypass (CPB) will be included. They will be randomized into two groups (experimental and control) with 80 patients each. Subjects in the experimental group will receive 400 mg of silymarin three days preoperatively, while subjects in the control group will receive standard therapy. The occurrence of POAF after CABG surgery will be the primary outcome, which will be defined as any dysrhythmia that represents the ECG characteristics of atrial fibrillation lasting at least 30 s on a rhythm strip or 12-lead ECG. Secondary outcomes will include postoperative values of inflammation markers, length of stay in the ICU, length of hospitalization, and occurrence of postoperative complications (pericardial effusion, stroke, in-hospital death). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
Recruiting |
NCT04870424 -
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
|
Phase 3 | |
Completed |
NCT05818592 -
Screening for Atrial Fibrillation With Self Pulse Monitoring
|
N/A | |
Active, not recruiting |
NCT05780320 -
A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
|
||
Active, not recruiting |
NCT03866148 -
Obstructive Sleep Apnoea and Cardiac Arrhythmias
|
N/A | |
Withdrawn |
NCT05656170 -
Stellate Ganglion to Prevent Atrial Fibrillation
|
N/A | |
Active, not recruiting |
NCT05255224 -
PARADISE: Predicting AF After Cardiac Surgery
|
||
Recruiting |
NCT04528511 -
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
|
||
Recruiting |
NCT04857268 -
Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120
|
N/A | |
Completed |
NCT04118270 -
Shared Decision-Making: AFib 2gether Mobile App
|
N/A | |
Active, not recruiting |
NCT03345615 -
Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT05841056 -
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
|
Phase 3 | |
Recruiting |
NCT06275503 -
STROKESTOP III - Optimized Method for Atrial Fibrillation Screening
|
N/A | |
Recruiting |
NCT05149820 -
Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments
|
Phase 4 | |
Completed |
NCT03221777 -
Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
|
||
Not yet recruiting |
NCT03991754 -
Prevention of New Onset AF After TAVI (PAF-TAVI Trial)
|
Phase 3 | |
Completed |
NCT03118518 -
STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
|
N/A | |
Completed |
NCT03552588 -
High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
|
||
Recruiting |
NCT05444335 -
Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years
|
N/A | |
Not yet recruiting |
NCT06458829 -
Promoting Atrial Fibrillation Screening in Primary Care
|
N/A |